Montag A & Associates Inc. Lowers Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Montag A & Associates Inc. decreased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 33.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,178 shares of the pharmacy operator’s stock after selling 3,589 shares during the quarter. Montag A & Associates Inc.’s holdings in Walgreens Boots Alliance were worth $67,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in WBA. First Financial Corp IN lifted its stake in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 885 shares in the last quarter. Golden State Wealth Management LLC purchased a new stake in Walgreens Boots Alliance during the fourth quarter worth about $26,000. TD Private Client Wealth LLC lifted its position in shares of Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 3,208 shares in the last quarter. Sentry Investment Management LLC purchased a new position in shares of Walgreens Boots Alliance in the third quarter valued at approximately $30,000. Finally, Eastern Bank acquired a new position in shares of Walgreens Boots Alliance in the third quarter valued at approximately $33,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on WBA. Evercore ISI increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Jefferies Financial Group decreased their price objective on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Royal Bank of Canada upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. TD Cowen decreased their price target on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research note on Tuesday, October 22nd. Finally, Bank of America increased their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $13.19.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $9.70 on Tuesday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $22.47. The firm has a 50-day simple moving average of $10.31 and a 200-day simple moving average of $9.72. The company has a market capitalization of $8.38 billion, a price-to-earnings ratio of -0.95, a price-to-earnings-growth ratio of 1.26 and a beta of 0.65.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same period last year, the business posted $0.66 EPS. The company’s revenue was up 7.6% on a year-over-year basis. On average, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.